Walkers (Cayman) acts for InSilico Medicine on $255 Million Series C Financing

Walkers (Cayman) is pleased to have acted as Cayman Islands counsel to InSilico Medicine in connection with its $255 Million Series C financing round.  Hong Kong-based InSilico is a global leader in end-to-end artificial intelligence for target discovery, small molecule chemistry and clinical development. Walkers is happy to continue its longstanding relationship in support of Insilico in this very important, impactful, and emerging field.

The Walkers team acted alongside Wilson Sonsini (Shanghai) and was led by Cayman Islands partner, Andrew Barker, with assistance from Jennifer Sangaroonthong (Associate) and Aoife Murphy (Associate).

Related Content